Hilary A. Rapkin - Nov 1, 2022 Form 4 Insider Report for WEX Inc. (WEX)

Role
Chief Legal Officer
Signature
/s/ Hilary Rapkin
Stock symbol
WEX
Transactions as of
Nov 1, 2022
Transactions value $
-$1,016,898
Form type
4
Date filed
11/3/2022, 05:19 PM
Previous filing
Jun 28, 2022
Next filing
Jan 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WEX Common Stock Sale -$298K -1.8K -12.74% $165.45 12.3K Nov 1, 2022 Direct
transaction WEX Common Stock Options Exercise $0 +4.36K +35.33% $0.00 16.7K Nov 1, 2022 Direct
transaction WEX Common Stock Sale -$719K -4.36K -26.11% $165.08 12.3K Nov 1, 2022 Direct F1
transaction WEX Common Stock Gift $0 -125 -1.01% $0.00 12.2K Nov 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WEX Stock Option (right to buy) Options Exercise $0 +4.36K $0.00* 0 Nov 1, 2022 Common Stock 4.36K $99.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price listed is a weighted average price for all shares sold. All shares were sold for between $164.99 and $165.26. Upon request, the reporting person will provide the Securities and Exchange Commission, WEX Inc. or any security holder of WEX Inc. with full information regarding the number of shares sold at each separate purchase price.
F2 Reflects the gift of common stock to a charitable donor advised fund.
F3 As noted on the Reporting Person's Form 4 dated March 2, 2021, half of the performance-based non-statutory stock options ("Performance-Based NSOs"), reported on the Reporting Person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.